References
- Bishop RP, Nelson G, Lambs J. Microencapsulation in yeast cells. J Microencapsul 1998; 15: 761–73
- Blanquet S, Marol-Bonnin S, Beyssac E, Pompon D, Renaud M, Alric M. The biodrug concept: An innovative approach to therapy. Trends in Biotechnol 2001; 19: 393–400
- Ci YX, Zang KS, Gao TY. FTIR study of microbes. Chem J Chinese Univ 2002; 6: 1047–9
- Dardelle G, Normand V, Steenhoudt M, Bouquerand P, Chevalier M, Baumgartner P. Flavour encapsulation and flavour-release performances of a commercial yeast-based delivery system. Food Hydrocolloids 2007; 21: 953–60
- Grant SM, Clissold SP. Itraconazole: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs 1989; 37: 310–44
- Folch J, Lees M, Stanley S. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chemis 1957; 226: 497–9
- Hong J, Kim J, Song Y, Park J, Kim C. A new self-emulsifying formulation of itraconazole with improved dissolution and oral absorption. J Control Release 2006; 110: 332–8
- Hausner HH. Friction conditions in a mass of metal powder. Int J Powder Metall 1967; 3: 7–13
- Jee H, Shin Y, Choi YC, Kim A, Myung GL. Dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: Intestinal first-pass effect. Antimicrob Agents Chemo 2004; 48: 1756–62
- Jung J, Yoo S, Lee K, Kim K, Yoon D, Lee K. Enhanced solubility and dissolution rates of itraconazole by a solid dispersion technique. Int J Pharm 1999; 187: 209–18
- Kasai T, Eguchi T, Ishiwaki N, Kaneshige J, Ozeki T, Yuasa H. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. I. AYC as a novel coating material. Int J Pharm 2000; 204: 53–9
- Kumar V, Kothari SH, Banker GS. Compression, compaction, and disintegration properties of low crystallinity celluloses produced using different agitation rates during their regeneration from phosphoric acid solutions. AAPS Pharm Sci Tech, 2001;2, article 7
- Lipinslki C. Poor aqueous solubility – an industry wide problem in drug discovery. Am Pharm Rev 2002; 5: 82–5
- Muller RH, Peters K. Nanosuspensions for the formulation of poorly water soluble drugs. I. Preparation by a size reduction technique. Int J Pharm 1998; 160: 229–37
- Northcote DH, Horne RW. The chemical composition and structure of yeast cell wall. Biochem J 1952; 51: 232–6
- Peeters J, Neeskens P, Tollenaere JP, Remoortere PV, Brewster M. Characterization of the interaction of 2-hydroxypropyl-β-cyclodextrin with itraconazole at pH 2, 4 and 7. J Pharm Sci 2002; 91: 1414–22
- Rabinow BE. Nanosuspensions in drug delivery. Nat Rev Drug Discov 2004; 3: 785–96
- Rabinowa B, Kipp J, Papadopoulos P, Wong J, Glosson J, Gass J, Sunc C, Wielgos T, White R, Cook C, et al. Itraconazole IV nanosuspension enhances efficacy through altered pharmacokinetics in the rat. Int J Pharm 2007; 339: 251–60
- Sajbidor J, Certik M, Grego J. Lipid analysis of baker's yeast. J Chrom 1994; 665: 191–5
- Shangraw RF, Wallace JW, Bowers FM. Morphology and functionality in tablet excipients for direct compression: Part I. Pharm Technol 1981; 5: 69–78
- Shi GR, Rao LQ, Yu HZ, Xiang H, Pen GP, Long S, Yang C. Yeast-cell-based microencapsulation of chlorogenic acid as a water-soluble antioxidant. J Food Eng 2007; 80: 1060–7
- Shi GR, Raoa L, Yu H, Xiang H, Yang H, Ji R. Stabilization and encapsulation of photosensitive resveratrol within yeast cells. Int J Pharm 2008; 349: 83–93
- Smith ID, Waters DG. Determination of residual solvent levels in bulk pharmaceuticals by capillary gas chromatography. Analyst 1991; 116: 1327–31
- Yang W, Tam J, Miller DA, Zhouc J, McConville JT, Johnstonb KP, Williams RO. High bioavailability from nebulized itraconazole nanoparticle dispersions with biocompatible stabilizers. Int J Pharm 2008; 361: 177–88
- Yilwoong Y, Yoon HJ, Kim BO, Shim M, Kim S, Hwang S, Seo MH. A mixed polymeric micellar formulation of itraconazole: Characteristics, toxicity and pharmacokinetics. J Control Release 2007; 117: 59–67
- Yuasa H, Kaneshige J, Ozeki T, Kasai T, Eguchi T, Ishiwaki N. Application of acid-treated yeast cell wall (AYC) as a pharmaceutical additive. II: Effects of curing on the medicine release from AYC-coated tablets. Int J Pharm 2000; 209: 69–77
- Wang X, Michoel A, Mooter G. Solid state characteristics of ternary solid dispersions composed of PVP VA64, Myrj 52 and itraconazole. Int J Pharm 2005; 303: 54–61